Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Scott B. Ullem
Director
Disclosures on record
30
Companies involved
2
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
CFO sold ~$664K of Edwards Lifesciences
Scheduled in advanceCFO sold ~$376K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
CFO sold ~$673K of Edwards Lifesciences
Scheduled in advanceCFO sold ~$431K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
CFO sold ~$650K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$832K of Edwards Lifesciences
Scheduled in advanceCFO sold ~$248K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.